End of last year, the U.S. Food and Drug Administration (FDA) issued an unpublished notice titled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal,” formally withdrawing its previously proposed rule on this topic. The withdrawal took effect upon the issuance of the notice. Under the now-withdrawn proposal, FDA had considered establishing specific […]